ClinicalTrials.gg
Not yet recruitingNCT05569798INSIGHTUpdated Oct 4, 2023

The INSIGHT Feasibility Study Ultrasound in the Intensive Care Unit: A Randomised Controlled Feasibility Trial

An interventional study of Whole body point of care ultrasound scan in Critical Illness, Cardiac Complication and Pleural Effusion, sponsored by King's College Hospital NHS Trust. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-04.

Primary conditionPleural EffusionRegistry: Critical IllnessReclassifiedWhy we changed it
Registry
Critical Illness — the first condition term the registry derived for this study.
ClinicalTrials.gg
Pleural Effusion
Why
  1. Critical Illness is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Pleural Effusion.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by King's College Hospital NHS Trust · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Point-of-care ultrasound (PoCUS) is a rapidly evolving method of clinical assessment within the intensive care unit (ICU) with training predominantly aimed at physicians. Routine whole-body PoCUS (lungs, heart, abdomen and blood vessels) when conducted by physicians benefits patient care and outcomes including reducing the risk of prolonged ICU stay (>7 days) and mechanical ventilation as well as reducing utilisation of other diagnostic tests. However, physician-only use of PoCUS does not allow for use as a routine assessment method in the ICU due to the low physician to patient ratio and poor ultrasound accreditation rate.

Providing other healthcare professionals such as Advanced Critical Care Practitioners (ACCPs), ICU nurses and physiotherapists with PoCUS skills increases the proportion of trained staff to perform routine PoCUS in the ICU. This could aid earlier identification of abnormal pathology, earlier treatment, and prevent patient deterioration. The advancement of handheld PoCUS technology is making ultrasound more portable, cheaper and easier to use.

The increased accessibility of PoCUS combined with growing evidence of its diagnostic accuracy compared to other modes of imaging means PoCUS use is gaining traction globally. However, little to no research exists investigating the feasibility of implementing scheduled interprofessional PoCUS in the ICU and its impact on patient outcomes.

This study aims to evaluate the acceptability and feasibility of a quick and simple whole body ultrasound scan performed by trained ACCPs, ICU nurses, physiotherapists, and doctors at set time points throughout the patients ICU stay. The investigators want to find out the most common barriers and facilitators to intervention implementation and to explore the key clinical outcomes for use in a future definitive RCT.

Read the detailed description

PoCUS is a non-invasive procedure that does not use harmful radiation. PoCUS therefore minimises patient risk and has superior diagnostic capabilities compared to the stethoscope. Non-medics can learn and utilise PoCUS with comparable accuracy. Routine whole-body PoCUS could enable more informed and timely clinical decision-making regarding lifesaving interventions such as patient positioning (proning), ventilatory support, and fluid balance optimisation. PoCUS could decrease time spent in diagnostic testing outside the ICU, minimising spread of infection through reduced patient contact, and reduce risk associated with patient transfers to scanning. Increased PoCUS use therefore has the potential to positively impact more patients, with less disruption to patient care.

In addition, increased routine PoCUS use by multiple professions will create a shared communication platform with the potential to enhance interdisciplinary collaboration. PoCUS use meets the growing demand for advanced assessment skills in the ICU, increasing autonomy and improving staff retention. PoCUS may reduce service costs by limiting the need for other imaging. In addition, the economic value of fewer diagnostic tests and the potential for improved patient outcomes could be significant. Storage solutions for diagnostic imaging present an ongoing challenge throughout the healthcare service. Imaging is stored on multiple platforms, making reviewing of images often location dependent. Identifying the most accessible storage platform for routine image review could significantly influence utilisation of images during patient assessment.

The investigator's aim is to evaluate the acceptability and feasibility of the INSIGHT Intervention within the ICU environment. This comprises performing a whole body PoCUS (INSIGHT) scan on days 1, 3, and 7 of ICU admission, with review by the clinical team.

The INSIGHT Scan is a whole-body PoCUS scan which comprises imaging the following windows:

  1. subcostal
  2. inferior vena cava cardiac view
  3. left hemidiaphragm
  4. bladder
  5. right hemidiaphragm
  6. six major central veins (left/right internal jugular/ subclavian/ femoral veins)

Design and Setting: A mixed-methods study across 2 adult ICUs (30 beds) within the critical care centre at KCH, London.

The Study will be conducted in two stages:

Stage 1 Aim: The aim of this stage is to identify and address the acceptability and feasibility of the INSIGHT intervention from the perspective of key stakeholders.

The primary objectives will be to:

  1. Assess barriers and facilitators to delivering the delivering the INSIGHT intervention
  2. Refine the INSIGHT intervention so that it is acceptable to key stakeholders
  3. To have a clear understanding of intervention fidelity and ability to recruit participants (33, 34)

The following feasibility outcomes will be evaluated:

  1. availability of a trained staff member to perform the INSIGHT scan when an eligible patient is identified
  2. barriers to completing the INSIGHT scan
  3. barriers to accessing INSIGHT scan images during ward round
  4. barriers to incorporating the INSIGHT scan into routine clinical care
  5. number of eligible patients (screening data)
  6. screening and recruitment methods (number of 'missed' patients and reason for non-enrolment)

ICU Patient Sample: Convenience sampling will be used to recruit 20 adult (18 years or over) ICU patients.

ICU Staff Sample: Prior to stage 1 commencement, a minimum of 10 staff members will have completed the training and will be approached for consent to participate in this study.

Fifteen INSIGHT-trained and non INSIGHT-trained clinical staff will be recruited using purposive sampling (ACCPs, nurses, doctors, physiotherapists) to either attend one of two focus groups.

Data collection methods:

  • Go-along interviews with trained staff whilst performing the INSIGHT scan
  • Ward round observations
  • Questionnaires will be distributed to staff before any patients receive an INSIGHT scan, the after 5, 10, 15, and 20 patients have been scanned
  • Focus groups

Stage 2 Aim: To evaluate the feasibility of the INSIGHT intervention trial design to inform a future adequately powered randomised controlled trial.

Primary Objective: To evaluate the feasibility of a randomised controlled trial of the INSIGHT Scanning Protocol.

Feasibility objectives:

  1. Recruitment rate and willingness of approached eligible patients to consent
  2. Number of complete scans (i.e., 6/6 windows)
  3. Reasons scans not performed/completed
  4. Time taken to perform and report INSIGHT scans
  5. Proportion of complete scan reports compared to the total number of scans performed
  6. Staff perceived feasibility of the INSIGHT Scan on days 1, 3, and 7 of ICU admission
  1. Adherence to the INSIGHT Scanning Protocol, measured by the number of INSIGHT scans and reports completed compared to the number required in the INSIGHT protocol design 7. Rate of adverse and serious adverse events

Exploratory clinical objectives:

  1. Number of diagnostic tests (chest X-ray, non-INSIGHT ultrasound, CT scans [excluding head]) per patient during ICU stay
  2. Radiation exposure (measured in mSv)
  3. Duration of mechanical ventilation
  4. ICU length of stay
  5. Number of nosocomial infections
  6. Number and type of incidental clinical findings detected using the INSIGHT scan and time to a clinical intervention to address this incidental clinical finding

Patient participant sample: The investigators will recruit 60 patients during the study.

Randomisation: Participants will be randomised to receive the INSIGHT intervention or standard care (no INSIGHT intervention) on a 1:1 basis.

02

Conditions studied

  • Critical Illness
  • Cardiac Complication
  • Pleural Effusion
  • Consolidation
  • Ascites
  • Thrombosis

Browse trials for

03

In context

Pleural Effusion Reclassified

241 studies on the registry are indexed under Pleural Effusion; 50 are open to participants now.

This study's planned enrollment of 120 is above the median of 80 across 142 interventional studies indexed under Pleural Effusion.

Browse Pleural Effusion studies →

Lead sponsor

King's College Hospital NHS Trust is the lead sponsor of 171 studies on the registry; 56 are open to participants now.

Compared within Pleural Effusion, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Critical Illness. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Patient Inclusion Criteria:

  1. Patients 18 years of age or more
  2. Critically ill patient requiring level 2/3 care
  3. Provides consent to participate (or consent given by substitute decision maker)
  4. Anticipated to be admitted to ICU for at least 72 hours from time of admission

Patient Exclusion Criteria:

  1. Injuries that prevent probe positioning:

    1. Dressings that restrict the INSIGHT window views
    2. Flail chest
    3. Other unstable fractures that might prevent scanning
    4. Open abdominal/thorax wounds
    5. Surgical emphysema
  2. Uncontrolled agitation or pain: this will make scanning more challenging and affect image acquisition
  3. Clinical instability requiring prioritisation of stabilising or resuscitative care
  4. Allergy to ultrasound gel
  5. Anticipated withdrawal of care in the next 24 hours

Staff Inclusion Criteria

i. Nurse, ACCP, physiotherapist, or doctor ii. Completion of an advanced course in ICU nursing, ACCP course, ICU physiotherapy or medicine iii. Working in a participating ICU for a minimum of 6 months before enrolment on training course iv. Competent or undergoing training in the INSIGHT Scan

ICU staff exclusion criteria

i. Any injuries or musculoskeletal conditions that would be exacerbated by performing ultrasound ii. On rotation or planning on leaving ICU role in 6 or less months

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • No intervention
    Standard care

    Thirty patients will receive standard care (regular ICU treatment without any restriction to usual medical care). INSIGHT scans will not be performed on these patients. However, other forms of ultrasound scanning will be permitted in this group. For example, departmental ultrasound scans (full echocardiography, liver, or vascular ultrasound assessment); transoesophageal echocardiography; transcranial doppler; any form of PoCUS other than the INSIGHT scan.

  • Experimental
    Standard care + the INSIGHT intervention

    Thirty patients will receive standard care + the INSIGHT intervention. The INSIGHT intervention is described in detail in section 5.7.1. INSIGHT scans will be performed by staff trained in the INSIGHT Training and Competency Programme on days 1 (0-36 hours), 3 (72-96 hours) and 7 (6 to 8 days) from ICU admission. Scans will only be performed at these timepoints if the patient is still admitted to the ICU.

    Diagnostic Test: Whole body point of care ultrasound scan

Interventions

  • Diagnostic testWhole body point of care ultrasound scan

    The INSIGHT Scan is a whole-body PoCUS scan which comprises imaging the following windows: 1. subcostal 2. inferior vena cava cardiac view 3. left hemidiaphragm 4. bladder 5. right hemidiaphragm 6. six major central veins (left/right internal jugular/ subclavian/ femoral veins) The scan should take no more than 10 minutes to perform. Simple yes/no questions are asked for each window to identify any significant abnormalities. For example, is the left ventricle bigger than the right ventricle; is there a pleural effusion; is the bladder distended etc. The scan is reported in the intensive care online medical notes and reviewed by the clinical team as soon as possible.

    Also known as: The INSIGHT scan

06

What researchers measure

Primary outcomes

  1. Adherence to the INSIGHT Scanning Protocol, measured by the number of INSIGHT scan reports completed compared to the number required in the INSIGHT protocol design

    Scanning timepoints are on days 1, 3, and 7 of ICU admission. However the patient may have been discharged before the second or third timepoint. This measure therefore captures feasibility of performing the scan during the available opportunities only.

    Time frame: Day of ICU admission (day 1) to day 7 of ICU admission

  2. Recruitment rate and willingness of approached eligible patients to consent

    We will capture those who do not consent in a screening log

    Time frame: Through to study completion, approximately 18 months

  3. Number of complete scans (i.e., 6/6 windows)

    The proportion of ultrasound scans that are completed

    Time frame: Through to study completion, approximately 18 months

  4. Reasons scans not performed/completed

    We will capture reasons for not completing scan in the ultrasound report

    Time frame: Through to study completion, approximately 18 months

  5. Proportion of complete scan reports compared to the total number of scans performed

    Time frame: Through to study completion, approximately 18 months

  6. Staff perceived feasibility of the INSIGHT Scan on days 1, 3, and 7 of ICU admission

    We will capture this during semi-structured 30 minute interviews

    Time frame: 18 months

  7. Rate of adverse and serious adverse events

    Time frame: Through to study completion, approximately 18 months

Other outcomes

  1. Number of diagnostic tests (chest X-ray, non-INSIGHT ultrasound, CT scans [excluding head]) per patient during ICU stay

    Time frame: Day of ICU admission to day 28 or ICU discharge/death

  2. Radiation exposure

    measured in millisievert

    Time frame: Day of ICU admission to day 28 or ICU discharge/death

  3. Duration of mechanical ventilation

    Multiple episodes will be recorded if patient is reintubated

    Time frame: Day of ICU admission to day 28 or ICU discharge/death

  4. ICU length of stay

    Time frame: Day of ICU admission to day 28 or ICU discharge/death

  5. Number and type of nosocomial infections

    site of infection, organism confirmed by microbiology, antibiotic treatment, date started, date stopped will all be collected

    Time frame: Day of ICU admission to day 28 or ICU discharge/death

  6. Number and type of incidental clinical findings detected using the INSIGHT scan

    Findings include: Pericardial effusion; Dilated right ventricle; Abnormal contractility and function of the left or right ventricle; Lung consolidation; Pleural effusion; Presence of 3 or more B-lines; Abdominal fluid collection; Abnormal growth/ thrombus in any view

    Time frame: Day of ICU admission (day 1), day 3, and day 7 of ICU admission

  7. Time from ICU admission (or from INSIGHT scan if performed on days 3 and 7) to clinical

    Interventions include: Insertion of central venous catheter; Commencement of first vasopressors whilst in ICU; Renal filtration; Start of first antibiotics prescribed in ICU; Drain inserted (specify type); ECG; Insertion of urinary catheter; Repositioning of existing urinary catheter; Other (please specify)

    Time frame: Day of ICU admission to day 28 or ICU discharge/death

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — The data collected will only be used for publications relating to this trial. Relevant data to the publications will be published. More detailed datasets will be available on request. However these data cannot be used for any other research.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 4, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05569798
Responsible party
Sponsor
First posted
Oct 6, 2022
Start date
Dec 4, 2023 (estimated)
Primary completion
Dec 1, 2024 (estimated)
Completion
Dec 1, 2024 (estimated)
Last update
Oct 4, 2023

Study contacts

Eleanor Corcoran
Contact
e.corcoran@nhs.net
02032991038 ext. 31038
Phil Hopkins
Contact
p.hopkins@nhs.net
02032991038 ext. 31038
Eleanor Corcoran
principal investigator · Doctoral Research Fellow

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion